Refine by
Cannabinoids Equipment Supplied In Canada
6 equipment items found
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
IntegraSyn is InMed’s integrated cannabinoid synthesis system to manufacture pharmaceutical-grade cannabinoids. Our goal has always been to achieve an efficient, scalable, flexible and economical solution to produce cannabinoids with bio-identical structures to those found in nature. IntegraSyn™ is designed to produce rare ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
Our subsidiary, BayMedica, is a B2B supplier of highly pure, premium bioidentical rare cannabinoids as raw ingredients for health and wellness products. BayMedica has been able to reliably manufacture rare, minor cannabinoids that are bioidentical to those found in the plant. This means that our cannabinoids have an identical molecular ...
by:Tetra Bio-Pharma based inOrleans,, ONTARIO (CANADA)
Tetra Bio-Pharma is engaged in the development of an advanced and growing pipeline of biopharmaceuticals containing cannabinoids and other medicinal plant-based elements. With patients at the core of our mission, Tetra Bio-Pharma is focused on providing new and improved healthcare solutions centered around patient outcomes comprising prevention, treatment and overall ...
Manufactured by:Inversago Pharma based inMontreal, QUEBEC (CANADA)
It is involved in regulating several pathways linked to energy intake, reserves and overall expenditure. To do so, the cannabinoid-1 receptor (CB1) may be activated and deactivated such that it impacts many metabolic pathways involving several enzymes and proteins, e.g. leptin, insulin and ...
Manufactured by:CanaQuest Medical Corp. based inMississauga, ONTARIO (CANADA)
There are three major parts to the system, enzymes, receptors, and endocannabinoids. The body makes these molecules. Endocannabinoids are similar to cannabinoids, such as CBD. Researchers have isolated two critical endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG). The body produces them as they are needed, and they help the body run at peak ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
INM-088 is a topical eye drop formulation under development for the treatment of glaucoma. The active pharmaceutical ingredient (API) in INM-088 is cannabinol, also known as CBN, a rare cannabinoid showing promise in its potential to provide neuroprotection and to reduce intraocular pressure of the ...